61. Quality of life and its association with the nutritional status in Rifampicin-resistant/multidrug-resistant tuberculosis patients

Nguyen Thi Lien Ha, Vu Quoc Dat, Nguyen Binh Hoa, Nguyen Thu Anh, Gregory Fox

Main Article Content

Abstract

Tuberculosis (TB) remains a major global public health challenge, particularly in Rifampicin-resistant TB and multidrug-resistant TB (RR/MDR-TB) patients. This study aimed to assess the quality of life and its association with nutritional status, as determined by body mass index (BMI), in patients with RR/MDR-TB who received short-course treatment regimens in Vietnam. A descriptive, retrospective study was conducted on 521 TB patients diagnosed with RR/MDR-TB who underwent a short-course treatment at 35 healthcare facilities within the Drug-Resistant Tuberculosis Management Program across seven provinces in Vietnam. The distribution of quality-of-life levels was as follows: 36.42%, 28.90%, and 34.68% of patients reported “well below,” “below,” and “same or better” in physical health quality (PCS), respectively, while 73.03%, 15.03%, and 11.95% reported “well below,” “below,” and “same or better” in mental health quality (MCS), respectively. Among underweight and malnourished patients (BMI < 18.5), 97.9% experienced a "well below" or "below" quality of life. Similarly, 100% of overweight and obese patients (BMI ≥ 25) reported a "well below" or "below" quality of life. The overweight/obese group exhibited a significant decline in quality of life across most domains, particularly in psychological and social aspects. These findings highlight the need to integrate both physical and mental health support into RR/MDR-TB treatment, with an emphasis on early screening and intervention for psychological conditions to reduce disease burden and enhance treatment outcomes.

Article Details

References

1. World Health Organization. Global Tuberculosis Report 2024 [Internet]. Geneva. 2024.
2. Bộ Y tế. Hướng dẫn chẩn đoán, điều trị và dự phòng bệnh Lao. 2024.
3. Bahi G AB, M’Boh G, et al.,. Evaluation of the Hematological and Biochemical Markers of Iron Metabolism in Pulmonary Multidrug-Resistant Tuberculosis (MDR-TB). J Trop Med Health: JTMH-132. 2018.
4. Barreto-Duarte B A-PM NB, Sobral L, Rodrigues MMS, Queiroz ATL, et al.,. Tuberculosis burden and determinants of treatment out- comes according to age in Brazil: a nationwide study of 896,314 cases reported between 2010 and 2019. Front Med (Lausanne) 2021; 8: 706689.
5. Demitto FO A-PM SC, Sant’Anna FM, Arriaga MB, Andrade BB, et al.,. Impact of persistent anemia on systemic inflammation and tuberculosis outcomes in persons living with HIV. Front Immunol [Internet]. 2021; 11.
6. Jaber AAS IB. Health-related quality of life of patients with multidrug-resistant tuberculosis in Yemen: prospective study. Health and Quality of Life Outcomes 2019; 17(1): 142.
7. Raman S RY, Meenakshi S, Varinder S, Vipin K.,. Quality of Life of Multi Drug Resistant Tuberculosis Patients: a Study of North India. Acta Medica Iranica. 2014; 52(6).
8. Dempster M DM. Measuring the health related quality of life of people with ischaemic heart disease. Heart (British Cardiac Society) 2000; 83(6): 641-644.
9. Iglesias C TD. Does length of questionnaire matter? A randomised trial of response rates to a mailed questionnaire. Journal of health services research & policy 2000; 5(4): 219-221.
10. Ngo-Metzger Q SD, Mangione CM, Gandek B, Hays RD.,. Evaluating the SF-36 Health Survey (Version 2) in Older Vietnamese Americans. Journal of aging and health 2008; 20(4): 420-436.
11. Song WM GJ, Xu TT, et al.,. Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019. BMC Pulm Med. 2021; 21(1): 399.
12. Juliasih NN, Mertaniasih NM, Hadi C, Soedarsono, Sari RM, Alfian IN. Factors Affecting Tuberculosis Patients’ Quality of Life in Surabaya, Indonesia. Journal of multidisciplinary healthcare. 2020; 13: 1475-1480.
13. Kurniawan S, Aphridasari, J. ., & Raharjo, A. F.,. Effect of Body Mass Index, Sputum Conversion Status, and Adverse Drug Events Severity On Health-Related Quality of Life of Drug-Resistant Tuberculosis Patients. Respiratory Science. 2025; 5(2): 72-81.
14. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Published online. https://appswhoint/iris/handle/10665/85839. 2011.
15. WHO. Body mass index (BMI). Global Health Observatory, World Health Organization. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index Accessed September 7, 2025.
16. Lê Đức Duy, Ngô Thanh Bình, Huỳnh Ngọc Vân Anh. Chất lượng cuộc sống và các yếu tố liên quan cuả bệnh nhân lao điều trị nội trú tại bệnh viện Phạm Ngọc Thạch thành phố Hồ Chí Minh. Tạp chí Nghiên cứu Y Học TP Hồ Chí Minh. 2022; Tập 26 (2): 303-309.
17. Tintin Sukartini GR, Ira Suarilah,. Various Factors Related to The Quality of Living Pulmonary Tuberculosis Patients. Sys Rev Pharm. 2020; 11(3): 925-929.
18. Milanović L, Živković D, Đošić A, et al. BMI, Body Image, and Quality of Life-Moderating Role of Physical Activity. 2022; 12(14): 7061.
19. Diallo A, Diallo BD, Camara LM, et al. Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study. BMC infectious diseases. 2020; 20(1): 315.